Rohto Pharmaceutical Co.,Ltd.
Research Rohto Pharmaceutical Co.,Ltd. (4527.T) on Bullrun: market cap JPY 664.23B, P/E 21.0, dividend yield 1.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4527.T
- ExchangeTSE
- CountryJapan
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
- CurrencyJPY
- Market capJPY 664.23B
- P/E21.0
- Dividend yield1.7%
- Financial periodFY2026
- RevenueJPY 343.73B
- Revenue growth11.4%
- Net incomeJPY 34.25B
- Free cash flowJPY 21.54B
- Gross margin56.1%
Valuation Snapshot
latest market cap is JPY 664.23B; P/E is 21.0; dividend yield is 1.7%.
Peer valuation comparison
Latest P/E is 20.99x versus a Consumer Defensive sector median of 16.79x (25.0% above).
Latest dividend yield is 1.72% versus a Consumer Defensive sector median of 2.92% (41.1% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 343.73B | JPY 34.25B | JPY 21.54B | 56.1% | 145.29 | JPY 86.82B | JPY 60.24B | JPY 301.83B |
| FY2025 | JPY 308.63B | JPY 30.84B | JPY 26.36B | 56.5% | 134.72 | JPY 77.16B | JPY 57.41B | JPY 263.37B |
| FY2024 | JPY 270.84B | JPY 30.94B | JPY 25.33B | 58.1% | 135.21 | JPY 89.21B | JPY 10.49B | JPY 246.32B |
| FY2023 | JPY 238.66B | JPY 26.38B | JPY 21.02B | 57.6% | 115.29 | JPY 79.95B | JPY 11.69B | JPY 209.57B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 664.23B | 21.0 | 1.7% | 50 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 50 JPY, yield 1.7%.
| Year | Dividends/share |
|---|---|
| FY2026 | 50 JPY |
| FY2025 | 41 JPY |
| FY2024 | 31 JPY |
| FY2023 | 24 JPY |
| FY2022 | 20.5 JPY |
About Rohto Pharmaceutical Co.,Ltd.
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods Japan, China, and internationally. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines;
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Rohto Pharmaceutical Co.,Ltd.'s market cap?
Rohto Pharmaceutical Co.,Ltd.'s market capitalization is JPY 664.23B.
What is Rohto Pharmaceutical Co.,Ltd.'s P/E ratio?
Rohto Pharmaceutical Co.,Ltd.'s price-to-earnings (P/E) ratio is 21.0.
Does Rohto Pharmaceutical Co.,Ltd. pay a dividend?
Rohto Pharmaceutical Co.,Ltd. has a dividend yield of 1.7%.
What does Rohto Pharmaceutical Co.,Ltd. do?
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods Japan, China, and internationally. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams.